Safety Monitoring of Disease-Modifying Therapies in Multiple -

Name: Safety Monitoring of Disease-Modifying Therapies in Multiple Sclerosis
Uploaded: 2024-05-02T21:03:32+00:00
Description: Aisha Elfasi, MD, Clinical and Research Fellow, Department of Neurology, Johns Hopkins University, provides an overview of the currently available disease-

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Multiple Sclerosis: Putting the Revised McDonald Criteria Into Practice
Multiple Sclerosis: Putting the Revised McDonald Criteria Into Practice
MS & Immune Disorders
Multiple Sclerosis: Putting the Revised McDonald Criteria Into Practice
John R. Ciotti, MD, MSCI
John R. Ciotti, MD, MSCI
Radiologic Differential Diagnosis of Multiple Sclerosis
Radiologic Differential Diagnosis of Multiple Sclerosis
MS & Immune Disorders
Radiologic Differential Diagnosis of Multiple Sclerosis
Jared V. Goodman, MD, PhD; Apisit Kaewsanit, MD
Jared V. Goodman, MD, PhD; Apisit Kaewsanit, MD
Clinical Neuroinflammatory Mimics of Multiple Sclerosis
Clinical Neuroinflammatory Mimics of Multiple Sclerosis
MS & Immune Disorders
Clinical Neuroinflammatory Mimics of Multiple Sclerosis
Derrick Robertson, MD; Abigail Demers, BS
Derrick Robertson, MD; Abigail Demers, BS
Kappa Free Light Chain Index in the Diagnosis of Multiple Sclerosis
Kappa Free Light Chain Index in the Diagnosis of Multiple Sclerosis
MS & Immune Disorders
Kappa Free Light Chain Index in the Diagnosis of Multiple Sclerosis
Jeffrey Dunn, MD
Jeffrey Dunn, MD